For example, loss of cGAS-STING signalling in hepatocellular carcinoma resulted in enhanced tumorigenicity and decreased CTL infiltration in non-small-cell lung carcinoma (NSCLC) [46,52]. This evidence concerns the gene STING1 and non-small cell lung carcinoma.